Literature DB >> 32124927

Applications and advances of CRISPR/Cas9 in animal cancer model.

Min Xu, Qiaoyou Weng, Jiansong Ji.   

Abstract

The recent developments of clustered regularly interspaced short palindromic repeats(CRISPR)/-associate protein 9 (CRISPR/Cas9) have got scientific interests due to the straightforward, efficient and versatile talents of it. Furthermore, the CRISPR/Cas9 system has democratized access to gene editing in many biological fields, including cancer. Cancer development is a multistep process caused by innate and acquired mutations and leads to the initiation and progression of tumorigenesis. It is obvious that establishing appropriate animal cancer models which can simulate human cancers is crucial for cancer research currently. Since the emergence of CRISPR/Cas9, considerable efforts have been taken by researchers to apply this technology in generating animal cancer models. Although there is still a long way to go we are happy to see the achievements we have made and the promising future we have.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  CRISPR/Cas9; animal; cancer model; gene editing

Mesh:

Year:  2020        PMID: 32124927     DOI: 10.1093/bfgp/elaa002

Source DB:  PubMed          Journal:  Brief Funct Genomics        ISSN: 2041-2649            Impact factor:   4.241


  2 in total

1.  Probing Vasoreactivity and Hypoxic Phenotype in Different Tumor Grafts Grown on the Chorioallantoic Membrane of the Chicken Embryo In Ovo Using MRI.

Authors:  Johanna Buschmann; Dorothea M Heuberger; Fatma Kivrak Pfiffner; Petra Wolint; Jae-Hwi Jang; Wolfgang Jungraithmayr; Pietro Giovanoli; Maurizio Calcagni; Conny F Waschkies
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

Review 2.  Current Applications and Future Perspectives of CRISPR-Cas9 for the Treatment of Lung Cancer.

Authors:  Markeshaw Tiruneh G/Medhin; Endeshaw Chekol Abebe; Tekeba Sisay; Nega Berhane; Tesfahun Bekele; Tadesse Asmamaw Dejenie
Journal:  Biologics       Date:  2021-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.